专利检索 ap:("Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.") AND inv:"LESERER, Michael" 第 1 页

1.

发明授权
USE OF EGFR TRANSACTIVATION INHIBITORS IN HUMAN CANCER 无效
标题翻译： EGFR抑制剂在TRANS激活人类癌症

公开(公告)号：EP1482964B1

公开(公告)日：2011-01-05

申请号：EP03714791.5

申请日：2003-03-07

申请人： Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.

发明人： ULLRICH, Axel , SCHÄFER, Beatrix , FISCHER, Oliver , GSCHWIND, Andreas , LESERER, Michael

IPC分类号： A61K38/16 , A61K38/18 , A61K38/48 , C07K16/28 , A61K31/381 , A61K31/16

CPC分类号： A61K31/517 , A61K31/381 , A61K38/00 , A61K2039/505 , G01N33/5011 , G01N33/5029 , G01N33/5041

摘要： The present invention relates to the use of a compound which is capable of inhibiting activation of a growth factor receptor of the EGFR-family for the prevention or treatment of processes associated with increased G-protein mediated signal transduction.